Vaishali Pharma Clarifies Preferential Allotment Consideration Following Share Valuation Adjustment
Vaishali Pharma Limited has confirmed a material adjustment to the consideration for a preferential allotment of equity shares set to Kesar Pharma Limited (KPL), ensuring alignment with the valuation determined by a Registered Valuer. The transaction involves the issuance of up to 61,23,000 equity shares of Vaishali Pharma on a preferential basis to KPL, executed through a swap of KPL shares.The company had previously received members' approval for this allotment via a special resolution passed through postal ballot on March 15, 2026. This initial approval was based on the acquisition of 21,52,575 equity shares of KPL at a value of Rs...